肥大细胞增多症-话题@MedSci

#肥大细胞增多症#

13篇内容 | 665人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1971942, encodeId=ebde19e194298, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=晚期全身性肥大细胞增多症患者的福音，Ayvakyt已获得CHMP的积极意见, objectType=article, longId=295076, objectId=3c842950e643, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c842950e643, replyNumber=0, likeNumber=32, createdTime=2022-11-04, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c842950e643, moduleTitle=晚期全身性肥大细胞增多症患者的福音，Ayvakyt已获得CHMP的积极意见, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c842950e643)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971941, encodeId=d64419e1941e0, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, objectType=article, longId=221681, objectId=c0b722168126, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0b722168126, replyNumber=0, likeNumber=32, createdTime=2022-10-25, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0b722168126, moduleTitle=Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0b722168126)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971940, encodeId=320219e194076, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, objectType=article, longId=221678, objectId=c95b2216e828, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c95b2216e828, replyNumber=0, likeNumber=42, createdTime=2022-06-07, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c95b2216e828, moduleTitle=Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c95b2216e828)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971939, encodeId=993619e1939ce, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=LEUKEMIA：完善的骨髓肥大细胞增多症诊断标准——欧洲肥大细胞增多症能力网络的提议, objectType=article, longId=217661, objectId=bb7f21e66165, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bb7f21e66165, replyNumber=0, likeNumber=34, createdTime=2021-10-31, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bb7f21e66165, moduleTitle=LEUKEMIA：完善的骨髓肥大细胞增多症诊断标准——欧洲肥大细胞增多症能力网络的提议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bb7f21e66165)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971938, encodeId=7fd819e1938ce, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Blood：遗传性α-胰蛋白酶血症是肥大细胞增多症的有效遗传生物标志物, objectType=article, longId=199614, objectId=0b99199614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b99199614a4, replyNumber=0, likeNumber=26, createdTime=2021-03-16, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b99199614a4, moduleTitle=Blood：遗传性α-胰蛋白酶血症是肥大细胞增多症的有效遗传生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b99199614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971937, encodeId=ae2019e193734, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, objectType=article, longId=182244, objectId=6b5518224444, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6b5518224444, replyNumber=0, likeNumber=36, createdTime=2020-07-05, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6b5518224444, moduleTitle=Lancet haemat：如何评估肥大细胞增多症患者的预后？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b5518224444)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971936, encodeId=00da19e19367d, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Blood：惰性系统性全身肥大细胞增多症, objectType=article, longId=167587, objectId=ff0316e5874b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ff0316e5874b, replyNumber=0, likeNumber=30, createdTime=2020-05-09, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ff0316e5874b, moduleTitle=Blood：惰性系统性全身肥大细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ff0316e5874b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971935, encodeId=cf1b19e19353f, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=NCCN临床实践指南：系统性肥大细胞增多症（2019.V2）, objectType=article, longId=150180, objectId=13cf15018008, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13cf15018008, replyNumber=0, likeNumber=24, createdTime=2019-06-21, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13cf15018008, moduleTitle=NCCN临床实践指南：系统性肥大细胞增多症（2019.V2）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13cf15018008)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971934, encodeId=5c6919e1934bc, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=NCCN临床实践指南：系统性肥大细胞增多症（2019.V1）, objectType=article, longId=148998, objectId=6ea51489984e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6ea51489984e, replyNumber=0, likeNumber=28, createdTime=2019-06-29, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ea51489984e, moduleTitle=NCCN临床实践指南：系统性肥大细胞增多症（2019.V1）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ea51489984e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971933, encodeId=b98019e193357, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性, objectType=article, longId=144728, objectId=744c144e286d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=744c144e286d, replyNumber=0, likeNumber=37, createdTime=2018-08-15, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=744c144e286d, moduleTitle=Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=744c144e286d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971932, encodeId=77f419e1932af, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=诺华试验性肥大细胞增多症药物midostaurin整体缓解率达60%, objectType=article, longId=72200, objectId=be55e220004, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=be55e220004, replyNumber=0, likeNumber=31, createdTime=2016-10-19, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=be55e220004, moduleTitle=诺华试验性肥大细胞增多症药物midostaurin整体缓解率达60%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be55e220004)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971931, encodeId=492719e1931d7, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=NEJM：米哚妥林治疗晚期系统性肥大细胞增多症疗效显著, objectType=article, longId=71887, objectId=bca1e18877e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bca1e18877e, replyNumber=0, likeNumber=31, createdTime=2016-10-09, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bca1e18877e, moduleTitle=NEJM：米哚妥林治疗晚期系统性肥大细胞增多症疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bca1e18877e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1971930, encodeId=226a19e19304d, content=<a href='/topic/show?id=4c4f81885b6' target=_blank style='color:#2F92EE;'>#肥大细胞增多症#</a>, objectTitle=The Lancet：反复发作的系统性肥大细胞增多症, objectType=article, longId=35511, objectId=96843551195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96843551195, replyNumber=0, likeNumber=32, createdTime=2014-11-07, rootId=0, userName=s_pl2008, userId=71f1477, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96843551195, moduleTitle=The Lancet：反复发作的系统性肥大细胞增多症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96843551195)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

肥大细胞增多症

2020-05-29

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

晚期全身性肥大细胞增多症患者的福音，Ayvakyt已获得CHMP的积极意见

2022-11-04

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Nat Med：晚期系统性肥大细胞增多症患者Avapritinib治疗的安全性和疗效

2022-10-25

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Nat Med：Avapritinib在晚期系统性肥大细胞增多症治疗中的安全性和疗效

2022-06-07

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

LEUKEMIA：完善的骨髓肥大细胞增多症诊断标准——欧洲肥大细胞增多症能力网络的提议

2021-10-31

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Blood：遗传性α-胰蛋白酶血症是肥大细胞增多症的有效遗传生物标志物

2021-03-16

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Lancet haemat：如何评估肥大细胞增多症患者的预后？

2020-07-05

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Blood：惰性系统性全身肥大细胞增多症

2020-05-09

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

NCCN临床实践指南：系统性肥大细胞增多症（2019.V2）

2019-06-21

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

NCCN临床实践指南：系统性肥大细胞增多症（2019.V1）

2019-06-29

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

Blood：CD44是系统性肥大细胞增多症的侵袭性受体，介导其侵袭性

2018-08-15

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

诺华试验性肥大细胞增多症药物midostaurin整体缓解率达60%

2016-10-19

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

NEJM：米哚妥林治疗晚期系统性肥大细胞增多症疗效显著

2016-10-09

s_pl2008 (审核中...)

前往app查看评论内容

#肥大细胞增多症#

The Lancet：反复发作的系统性肥大细胞增多症

2014-11-07

科室
- - 订阅+
  - 更多科室
工具
服务